Table 4.
Comparison of clinicopathological parameters of 97 locally advanced esophageal squamous cell carcinoma patients who received curative concurrent chemoradiotherapy according to VEGF day 28 level
| Characteristics | VEGF < 80 pg/mL group (N = 29) | VEGF > 80 pg/mL group (N = 68) | P value |
|---|---|---|---|
| Age | |||
| < 60 years | 21 (72%) | 43 (63%) | 0.38 |
| ≥ 60 years | 8 (28%) | 25 (37%) | |
| T status | |||
| 1 + 2 | 8 (28%) | 7 (10%) | 0.031a |
| 3 + 4 | 21 (72%) | 61 (90%) | |
| N status | |||
| 0 + 1 | 9 (31%) | 22 (32%) | 0.90 |
| 2 + 3 | 20 (69%) | 46 (68%) | |
| Stage | |||
| II + IIIA + IIIB | 11 (38%) | 21 (31%) | 0.50 |
| IIIC | 18 (62%) | 47 (69%) | |
| Grade | |||
| 1 + 2 | 22 (76%) | 49 (72%) | 0.70 |
| 3 | 7 (24%) | 19 (28%) | |
| Location | |||
| Upper | 14 (48%) | 26 (38%) | 0.36 |
| Middle + Lower | 15 (52%) | 42 (62%) | |
VEGF vascular endothelial growth factor
aStatistically significant